BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 25924914)

  • 1. Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma.
    Dai W; Cheung AK; Ko JM; Cheng Y; Zheng H; Ngan RK; Ng WT; Lee AW; Yau CC; Lee VH; Lung ML
    Cancer Med; 2015 Jul; 4(7):1079-90. PubMed ID: 25924914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
    Zhao W; Mo Y; Wang S; Midorikawa K; Ma N; Hiraku Y; Oikawa S; Huang G; Zhang Z; Murata M; Takeuchi K
    BMC Cancer; 2017 Jul; 17(1):489. PubMed ID: 28716111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes.
    Li L; Zhang Y; Fan Y; Sun K; Su X; Du Z; Tsao SW; Loh TK; Sun H; Chan AT; Zeng YX; Chan WY; Chan FK; Tao Q
    Epigenomics; 2015; 7(2):155-73. PubMed ID: 25479246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest.
    Zhang Y; Fan J; Fan Y; Li L; He X; Xiang Q; Mu J; Zhou D; Sun X; Yang Y; Ren G; Tao Q; Xiang T
    Clin Epigenetics; 2018 Feb; 10(1):26. PubMed ID: 30359298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic induction of cellular high CpG methylation by Epstein-Barr virus in malignant epithelial cells.
    Li L; Zhang Y; Guo BB; Chan FK; Tao Q
    Chin J Cancer; 2014 Dec; 33(12):604-8. PubMed ID: 25322866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of methylated genes and miRNA signatures in nasopharyngeal carcinoma by bioinformatics analysis.
    Wang Y; Zhao Q; Lan N; Wang S
    Mol Med Rep; 2018 Apr; 17(4):4909-4916. PubMed ID: 29393436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic landscape of nasopharyngeal carcinoma.
    Dai W; Zheng H; Cheung AK; Lung ML
    Chin Clin Oncol; 2016 Apr; 5(2):16. PubMed ID: 27121876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular profile of nasopharyngeal carcinoma: analysing tumour suppressor gene promoter hypermethylation by multiplex ligation-dependent probe amplification.
    Ooft ML; van Ipenburg J; van Loo R; de Jong R; Moelans C; Braunius W; de Bree R; van Diest P; Koljenović S; Baatenburg de Jong R; Hardillo J; Willems SM
    J Clin Pathol; 2018 Apr; 71(4):351-359. PubMed ID: 28893862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma.
    Shu XS; Li L; Ji M; Cheng Y; Ying J; Fan Y; Zhong L; Liu X; Tsao SW; Chan AT; Tao Q
    Carcinogenesis; 2013 Sep; 34(9):1984-93. PubMed ID: 23677067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker.
    Li J; Gong P; Lyu X; Yao K; Li X; Peng H
    Oncol Rep; 2014 May; 31(5):2206-12. PubMed ID: 24604064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel methylated gene in nasopharyngeal carcinoma: TTC40.
    Ayadi W; Allaya N; Frikha H; Trigui E; Khabir A; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
    Biomed Res Int; 2014; 2014():691742. PubMed ID: 25101295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aberrant promoter hypermethylation of CHFR in nasopharyngeal carcinoma].
    Huang T; Du C; Yu N; Xiao X; Zhou X; Wang S; Huang G; Zhang Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Aug; 25(16):746-50. PubMed ID: 22070084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.
    Yang X; Dai W; Kwong DL; Szeto CY; Wong EH; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lung ML
    Int J Cancer; 2015 Feb; 136(4):E127-35. PubMed ID: 25196065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
    Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of DERL3 via DNA methylation by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.
    Kondo S; Okabe A; Nakagawa T; Matsusaka K; Fukuyo M; Rahmutulla B; Dochi H; Mizokami H; Kitagawa Y; Kurokawa T; Mima M; Endo K; Sugimoto H; Wakisaka N; Misawa K; Yoshizaki T; Kaneda A
    Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166598. PubMed ID: 36372158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation.
    Cheung HW; Ching YP; Nicholls JM; Ling MT; Wong YC; Hui N; Cheung A; Tsao SW; Wang Q; Yeun PW; Lo KW; Jin DY; Wang X
    Mol Carcinog; 2005 Aug; 43(4):237-45. PubMed ID: 15937956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.
    Liu XQ; Chen HK; Zhang XS; Pan ZG; Li A; Feng QS; Long QX; Wang XZ; Zeng YX
    Int J Cancer; 2003 Aug; 106(1):60-5. PubMed ID: 12794757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation biomarkers for nasopharyngeal carcinoma.
    Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
    PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.